HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin R Guertin Selected Research

histaminol (IMET)

1/2021MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin R Guertin Research Topics

Disease

5Type 2 Diabetes Mellitus (MODY)
04/2013 - 07/2003
1Hypoxia (Hypoxemia)
01/2021
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2021
1Lipidoses
08/2012
1Acute Coronary Syndrome
01/2007
1Thrombosis (Thrombus)
01/2007

Drug/Important Bio-Agent (IBA)

3GlucokinaseIBA
04/2013 - 01/2006
1histaminol (IMET)IBA
01/2021
1GlobinsIBA
01/2021
1Sickle HemoglobinIBA
01/2021
1ThioureaIBA
08/2012
1ThiazolesIBA
08/2012
1PyrazinesIBA
08/2012
13- cyclopentyl- 2- (4- methanesulfonylphenyl)- N- thiazol- 2- yl- propionamideIBA
05/2010
1otamixabanIBA
01/2007
1Glucose (Dextrose)FDA LinkGeneric
07/2003
1Blood Glucose (Blood Sugar)IBA
07/2003